⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PYPD News
PolyPid Ltd. Ordinary Shares
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
globenewswire.com
PYPD
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026
globenewswire.com
PYPD
PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting
globenewswire.com
PYPD
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
globenewswire.com
PYPD
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application
globenewswire.com
PYPD
PolyPid Announces Participation in Upcoming Investor Conferences
globenewswire.com
PYPD
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
globenewswire.com
PYPD
PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026
globenewswire.com
PYPD
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors
globenewswire.com
PYPD
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission
globenewswire.com
PYPD